Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 258

1.

Percutaneous coronary intervention with transcatheter aortic valve replacement makes no difference! None? Really?

Block PC, Kumar A.

Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28686. [Epub ahead of print]

PMID:
31957951
2.

The clipping enigma.

Lisko JC, Block PC.

Catheter Cardiovasc Interv. 2019 Nov 15;94(6):827-828. doi: 10.1002/ccd.28567.

PMID:
31737989
3.

Thrombocytopenia after transcatheter aortic valve replacement: What is really going on?

Block PC, Lisko JC.

Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1352-1353. doi: 10.1002/ccd.28353.

PMID:
31172677
4.

Postinfarction Ventricular Septal Defect Closure.

Kamioka N, Lederman RJ, Greenbaum AB, Khan JM, Yousef A, Gleason PT, Grubb KJ, Block PC, Leshnower B, Babaliaros VC.

Circ Cardiovasc Interv. 2019 May;12(5):e007788. doi: 10.1161/CIRCINTERVENTIONS.119.007788. No abstract available.

PMID:
31088121
5.

Repeat Pulmonary Valve Replacement: Similar Intermediate-Term Outcomes With Surgical and Transcatheter Procedures.

Caughron H, Kim D, Kamioka N, Lerakis S, Yousef A, Maini A, Reginauld S, Sahu A, Shashidharan S, Jokhadar M, Rodriguez FH 3rd, Book WM, McConnell M, Block PC, Babaliaros V.

JACC Cardiovasc Interv. 2018 Dec 24;11(24):2495-2503. doi: 10.1016/j.jcin.2018.07.042. Epub 2018 Nov 28.

6.

Septal rupture closure: Still a challenge.

Kamioka N, Block PC.

Catheter Cardiovasc Interv. 2018 Nov 15;92(6):1116-1117. doi: 10.1002/ccd.27956.

PMID:
30478881
7.

Paravalvular leak after transcatheter aortic valve replacement: Avoid it or treat it if you can!

Kumar A, Block PC.

Catheter Cardiovasc Interv. 2018 Nov 1;92(5):981-982. doi: 10.1002/ccd.27940.

PMID:
30450708
8.

BI-SILICA During Transcatheter Aortic Valve Replacement for Noncalcific Aortic Insufficiency: Initial Human Experience.

Kamioka N, Lederman RJ, Khan JM, Lerakis S, Yousef A, Gleason PT, Grubb KJ, Guyton RA, Leshnower B, Block PC, Greenbaum AB, Babaliaros VC.

JACC Cardiovasc Interv. 2018 Nov 12;11(21):2237-2239. doi: 10.1016/j.jcin.2018.08.015. No abstract available.

9.

Pulmonary Venous Waveforms Predict Rehospitalization and Mortality After Percutaneous Mitral Valve Repair.

Corrigan FE 3rd, Chen JH, Maini A, Lisko JC, Alvarez L, Kamioka N, Reginauld S, Gleason PT, Condado JF, Wei JW, Binongo JN, Keegan P, Howell S, Thourani VH, Block PC, Clements SD, Babaliaros VC, Lerakis S.

JACC Cardiovasc Imaging. 2019 Oct;12(10):1905-1913. doi: 10.1016/j.jcmg.2018.07.014. Epub 2018 Sep 12.

PMID:
30219407
10.

Comparison of Clinical and Echocardiographic Outcomes After Surgical Redo Mitral Valve Replacement and Transcatheter Mitral Valve-in-Valve Therapy.

Kamioka N, Babaliaros V, Morse MA, Frisoli T, Lerakis S, Iturbe JM, Binongo J, Corrigan F, Yousef A, Gleason P, Wells JA 4th, Caughron H, Dong A, Rodriguez E, Leshnower B, O'Neill W, Paone G, Eng M, Guyton R, Block PC, Greenbaum A.

JACC Cardiovasc Interv. 2018 Jun 25;11(12):1131-1138. doi: 10.1016/j.jcin.2018.03.011.

11.

Transcatheter treatment of aortic regurgitation: Still enigmatic.

Block PC.

Catheter Cardiovasc Interv. 2018 Jun;91(7):1352-1353. doi: 10.1002/ccd.27652.

PMID:
29894586
12.

PFO Closure for Cryptogenic Stroke.

Mi MY, Block PC, Broderick JP.

N Engl J Med. 2018 Apr 26;378(17):1639-1642. doi: 10.1056/NEJMclde1715853. No abstract available.

PMID:
29694824
13.

Predictors and Clinical Outcomes of Next-Day Discharge After Minimalist Transfemoral Transcatheter Aortic Valve Replacement.

Kamioka N, Wells J, Keegan P, Lerakis S, Binongo J, Corrigan F, Condado J, Patel A, Forcillo J, Ogburn L, Dong A, Caughron H, Simone A, Leshnower B, Devireddy C, Mavromatis K, Guyton R, Stewart J, Thourani V, Block PC, Babaliaros V.

JACC Cardiovasc Interv. 2018 Jan 22;11(2):107-115. doi: 10.1016/j.jcin.2017.10.021.

14.

Long-Term Outcomes With Transcatheter Aortic Valve Replacement in Women Compared With Men: Evidence From a Meta-Analysis.

Saad M, Nairooz R, Pothineni NVK, Almomani A, Kovelamudi S, Sardar P, Katz M, Abdel-Wahab M, Bangalore S, Kleiman NS, Block PC, Abbott JD.

JACC Cardiovasc Interv. 2018 Jan 8;11(1):24-35. doi: 10.1016/j.jcin.2017.08.015. Epub 2017 Oct 18. Review.

15.

Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis and Mitral Regurgitation.

Mavromatis K, Thourani VH, Stebbins A, Vemulapalli S, Devireddy C, Guyton RA, Matsouaka R, Ghasemzadeh N, Block PC, Leshnower BG, Stewart JP, Rumsfeld JS, Lerakis S, Babaliaros V.

Ann Thorac Surg. 2017 Dec;104(6):1977-1985. doi: 10.1016/j.athoracsur.2017.05.065. Epub 2017 Sep 29.

PMID:
28965619
16.

Readmission rates after transcatheter aortic valve replacement in high- and extreme-risk patients with severe aortic stenosis.

Forcillo J, Condado JF, Binongo JN, Lasanajak Y, Caughron H, Babaliaros V, Devireddy C, Leshnower B, Guyton RA, Block PC, Simone A, Keegan P, Khairy P, Thourani VH.

J Thorac Cardiovasc Surg. 2017 Aug;154(2):445-452. doi: 10.1016/j.jtcvs.2017.03.144. Epub 2017 Apr 18.

17.

Anatomical risk models for paravalvular leak and landing zone complications for balloon-expandable transcatheter aortic valve replacement.

Condado JF, Corrigan FE 3rd, Lerakis S, Parastatidis I, Stillman AE, Binongo JN, Stewart J, Mavromatis K, Devireddy C, Leshnower B, Guyton R, Forcillo J, Patel A, Thourani VH, Block PC, Babaliaros V.

Catheter Cardiovasc Interv. 2017 Oct 1;90(4):690-700. doi: 10.1002/ccd.26987. Epub 2017 May 4.

PMID:
28471092
18.

Outcomes After Paravalvular Leak Closure: Transcatheter Versus Surgical Approaches.

Wells JA 4th, Condado JF, Kamioka N, Dong A, Ritter A, Lerakis S, Clements S, Stewart J, Leshnower B, Guyton R, Forcillo J, Patel A, Thourani VH, Block PC, Babaliaros V.

JACC Cardiovasc Interv. 2017 Mar 13;10(5):500-507. doi: 10.1016/j.jcin.2016.11.043.

19.

Gender inequalities in transcatheter aortic valve replacement: The jury is still out.

Condado JF, Block PC.

Catheter Cardiovasc Interv. 2017 Feb 15;89(3):436-437. doi: 10.1002/ccd.26949. No abstract available.

PMID:
28220647
20.

End-stage renal disease and severe aortic stenosis: Does valve replacement improve one-year outcomes?

Condado JF, Maini A, Leshnower B, Thourani V, Forcillo J, Devireddy C, Mavromatis K, Sarin EL, Stewart J, Guyton R, Simone A, Keegan P, Lerakis S, Block PC, Babaliaros V.

Catheter Cardiovasc Interv. 2017 May;89(6):1109-1115. doi: 10.1002/ccd.26875. Epub 2017 Feb 17.

PMID:
28211605
21.

A complex transcatheter mitral valve replacement and repair for the treatment of refractory severe mitral regurgitation.

Condado JF, Babaliaros VC, Thourani VH, Jensen HK, Kim DW, Kaebnick BW, Block PC, Lerakis S.

Hellenic J Cardiol. 2016 Sep - Oct;57(5):348-350. doi: 10.1016/j.hjc.2015.06.005. Epub 2017 Jan 23. No abstract available.

22.

If TAVR Cannot Be Transfemoral, Then What?

Block PC, Mack M.

JACC Cardiovasc Interv. 2016 Nov 28;9(22):2326-2328. doi: 10.1016/j.jcin.2016.09.021. No abstract available.

23.

Does minimalist transfemoral transcatheter aortic valve replacement produce better survival in patients with severe chronic obstructive pulmonary disease?

Condado JF, Haider MN, Lerakis S, Keegan P, Caughron H, Thourani VH, Devireddy C, Leshnower B, Mavromatis K, Sarin EL, Stewart J, Guyton R, Forcillo J, Patel A, Simone A, Block PC, Babaliaros V.

Catheter Cardiovasc Interv. 2017 Mar 1;89(4):775-780. doi: 10.1002/ccd.26683. Epub 2016 Nov 12.

PMID:
27862901
24.

Should We Perform Carotid Doppler Screening Before Surgical or Transcatheter Aortic Valve Replacement?

Condado JF, Jensen HA, Maini A, Ko YA, Rajaei MH, Tsai LL, Devireddy C, Leshnower B, Mavromatis K, Sarin EL, Stewart J, Guyton RA, Babaliaros V, Chen EP, Halkos M, Simone A, Keegan P, Block PC, Thourani VH; Emory Structural Heart and Valve Center.

Ann Thorac Surg. 2017 Mar;103(3):787-794. doi: 10.1016/j.athoracsur.2016.06.076. Epub 2016 Oct 4.

PMID:
27717427
25.

Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) can risk stratify patients in transcatheter aortic-valve replacement (TAVR).

Condado JF, Junpaparp P, Binongo JN, Lasanajak Y, Witzke-Sanz CF, Devireddy C, Leshnower B, Mavromatis K, Stewart J, Guyton R, Wheeler D, Forcillo J, Patel A, Block PC, Thourani V, Rangaswami J, Babaliaros V.

Int J Cardiol. 2016 Nov 15;223:444-449. doi: 10.1016/j.ijcard.2016.08.260. Epub 2016 Aug 15.

PMID:
27544602
26.

Balloon Versus Computed Tomography Sizing of the Aortic Annulus for Transcatheter Aortic Valve Replacement and the Impact of Left Ventricular Outflow Tract Calcification and Morphology on Sizing.

Condado JF, Lerakis S, Stewart J, Jensen H, Henry TS, Ko SM, Stillman A, Rajaei MH, Mavromatis K, Devireddy C, Sarin E, Leshnower B, Guyton R, Kaebnick B, Thourani VH, Block PC, Babaliaros V.

J Invasive Cardiol. 2016 Jul;28(7):295-304. Epub 2016 Apr 15.

27.

Is it really "paradoxical" or just the ventricle?

Condado JF, Block PC.

Catheter Cardiovasc Interv. 2016 Mar;87(4):805-6. doi: 10.1002/ccd.26470.

PMID:
26994985
28.

"Like a Patient Etherized Upon a Table"? - Not Exactly.

Block PC.

J Invasive Cardiol. 2015 Nov;27(11):508-9. No abstract available.

29.

Understanding rare comorbidities in TAVR.

Block PC.

Catheter Cardiovasc Interv. 2015 Nov;86(5):895-6. doi: 10.1002/ccd.26244.

PMID:
26490805
30.

Minimalist transcatheter aortic valve replacement: The new standard for surgeons and cardiologists using transfemoral access?

Jensen HA, Condado JF, Devireddy C, Binongo J, Leshnower BG, Babaliaros V, Sarin EL, Lerakis S, Guyton RA, Stewart JP, Syed AQ, Mavromatis K, Kaebnick B, Rajaei MH, Tsai LL, Rahman A, Simone A, Keegan P, Block PC, Thourani VH.

J Thorac Cardiovasc Surg. 2015 Oct;150(4):833-9. doi: 10.1016/j.jtcvs.2015.07.078. Epub 2015 Jul 30.

31.

Transcatheter Aortic Valve Replacement Results in Improvement of Pulmonary Function in Patients With Severe Aortic Stenosis.

Gilmore RC, Thourani VH, Jensen HA, Condado J, Binongo JN, Sarin EL, Devireddy CM, Leshnower B, Mavromatis K, Syed A, Guyton RA, Block PC, Simone A, Keegan P, Stewart J, Rajaei M, Kaebnick B, Lerakis S, Babaliaros VC.

Ann Thorac Surg. 2015 Dec;100(6):2167-73. doi: 10.1016/j.athoracsur.2015.06.008. Epub 2015 Aug 13.

PMID:
26277560
32.

Is there life after transcatheter aortic valve replacement?

Block PC.

JACC Cardiovasc Interv. 2015 Apr 27;8(5):654-6. doi: 10.1016/j.jcin.2015.02.003. No abstract available.

33.

The transseptal conundrum.

Block PC.

JACC Cardiovasc Interv. 2015 Mar;8(3):460-461. doi: 10.1016/j.jcin.2015.01.001. Epub 2015 Feb 18. No abstract available.

34.

Evolving TAVR, and the need for intelligent design.

Block PC.

Catheter Cardiovasc Interv. 2015 Mar;85(4):655-6. doi: 10.1002/ccd.25847. No abstract available.

PMID:
25702911
35.

I'll bet you a nickel you don't ask.

Block PC.

J Invasive Cardiol. 2015 Feb;27(2):105. No abstract available.

PMID:
25661762
36.

High-risk patients with inoperative aortic stenosis: use of transapical, transaortic, and transcarotid techniques.

Thourani VH, Li C, Devireddy C, Jensen HA, Kilgo P, Leshnower BG, Mavromatis K, Sarin EL, Nguyen TC, Kanitkar M, Guyton RA, Block PC, Maas AL, Simone A, Keegan P, Merlino J, Stewart JP, Lerakis S, Babaliaros V.

Ann Thorac Surg. 2015 Mar;99(3):817-23; discussion 823-5. doi: 10.1016/j.athoracsur.2014.10.012. Epub 2015 Jan 14.

PMID:
25596868
37.

Whither platelets after TAVR?

Block PC.

Catheter Cardiovasc Interv. 2015 Jan 1;85(1):138. doi: 10.1002/ccd.25739. No abstract available.

PMID:
25521932
38.

Comprehensive analysis of mortality among patients undergoing TAVR: results of the PARTNER trial.

Svensson LG, Blackstone EH, Rajeswaran J, Brozzi N, Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Tuzcu EM, Webb JG, Kapadia S, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Thourani VH, Pichard AD, Bavaria JE, Herrmann HC, Williams MR, Babaliaros V, Généreux P, Akin JJ; PARTNER Trial Investigators.

J Am Coll Cardiol. 2014 Jul 15;64(2):158-68. doi: 10.1016/j.jacc.2013.08.1666.

39.

Fixing that vexing paravalvar leak.

Block PC.

Catheter Cardiovasc Interv. 2013 Aug 1;82(2):312. doi: 10.1002/ccd.25080. No abstract available.

PMID:
23878038
40.

Crouching tiger, lipid plaque.

Block PC.

Catheter Cardiovasc Interv. 2013 Feb;81(3):538-9. doi: 10.1002/ccd.24818. No abstract available.

PMID:
23418118
41.

Long-term outcomes after percutaneous patent foramen ovale closure.

Nagpal SV, Lerakis S, Flueckiger PB, Halista M, Willis P, Block PC, Douglas JS, Morris DC, Liff DA, Stewart J, Devireddy C, Veledar E, Nahab FB, Babaliaros VC.

Am J Med Sci. 2013 Sep;346(3):181-6. doi: 10.1097/MAJ.0b013e318276b071.

PMID:
23328836
42.

No good deed goes unpunished: persistent interatrial septal defect after transcatheter transseptal therapy.

Block PC.

Catheter Cardiovasc Interv. 2012 Oct 1;80(4):686. doi: 10.1002/ccd.24609. No abstract available.

PMID:
22996930
43.

Carotid artery access for transcatheter aortic valve replacement.

Guyton RA, Block PC, Thourani VH, Lerakis S, Babaliaros V.

Catheter Cardiovasc Interv. 2013 Oct 1;82(4):E583-6. doi: 10.1002/ccd.24596. Epub 2013 Mar 28.

PMID:
22887932
44.

Never too old to learn new tricks?

Block PC.

Catheter Cardiovasc Interv. 2012 Jul 1;80(1):91-2. doi: 10.1002/ccd.24491. No abstract available.

PMID:
22736588
45.

Lessons from the learning curve.

Block PC.

JACC Cardiovasc Interv. 2012 Jan;5(1):80-1. doi: 10.1016/j.jcin.2011.10.008. Epub 2011 Dec 21. No abstract available.

46.

Lowering the price to pay for TAVI.

Block PC.

J Invasive Cardiol. 2011 May;23(5):185. No abstract available.

47.

The LAA occlusion Foxtrot: steps forward; steps back.

Block PC.

Catheter Cardiovasc Interv. 2011 Apr 1;77(5):707-8. doi: 10.1002/ccd.23083. No abstract available.

PMID:
21433273
48.

Left ventricular puncture: no frontier is risk free.

Block PC.

Catheter Cardiovasc Interv. 2010 Dec 1;76(7):998-9. doi: 10.1002/ccd.22894. No abstract available.

PMID:
21108375
49.

Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.

Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators.

N Engl J Med. 2010 Oct 21;363(17):1597-607. doi: 10.1056/NEJMoa1008232. Epub 2010 Sep 22.

50.

Warfarin or no warfarin? That is the question.

Block PC.

Catheter Cardiovasc Interv. 2010 Aug 1;76(2):193. doi: 10.1002/ccd.22707. No abstract available.

PMID:
20665858

Supplemental Content

Loading ...
Support Center